Form 4: Artivion Executive's Stock Grant and Tax-Related Sale

Artivion's EVP, COO, CFO & Treasurer, Lance A. Berry, reported the vesting of performance stock units and a subsequent sale of shares to cover tax obligations.

Summary

• Lance A. Berry, EVP, COO, CFO & Treasurer of Artivion, Inc. (AORT), reported transactions involving the company's common stock.
• On March 2, 2026, Berry acquired 40,874 shares of common stock at a price of $0, representing the vesting of one-third of performance stock units granted on February 28, 2025.
• Following this acquisition, Berry's direct beneficial ownership increased to 217,143 shares.
• On March 3, 2026, Berry sold 6,316 shares of common stock at a price of $37.7756 per share.
• This sale was a "sell to cover" transaction, executed to satisfy tax withholding obligations arising from the vesting of the performance stock units and was not a discretionary transaction.
• After the sale, Berry's direct beneficial ownership stands at 210,827 shares.
• The remaining performance stock units from the February 2025 grant are scheduled to vest in two equal tranches: one-third on February 28, 2027, and one-third on February 28, 2028, contingent on continued employment.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. The vesting of performance stock units is a positive for executive compensation and retention, while the 'sell to cover' transaction is a routine, non-discretionary event with minimal negative implications.

Positives

• Lance A. Berry, a key executive, received a grant of 40,874 shares of common stock through the vesting of performance stock units, indicating continued alignment of executive incentives with shareholder value.
• The future vesting schedule for additional performance stock units in 2027 and 2028 suggests ongoing executive retention and long-term performance incentives.

Negatives

• A sale of 6,316 shares occurred, reducing the executive's direct beneficial ownership by that amount.

Future Outlook

The filing indicates a future vesting schedule for Lance A. Berry's performance stock units, with one-third of the remaining shares eligible to vest on February 28, 2027, and another one-third on February 28, 2028, contingent upon his continued employment with Artivion, Inc.

Industry Context

StockSavvy.ai notes that executive stock grants and subsequent 'sell to cover' transactions for tax purposes are standard practices in executive compensation across various industries. This filing reflects a routine compensation event rather than a strategic shift or response to broader industry trends.

Stakeholder Impact

• Shareholders: The vesting of performance stock units aligns executive incentives with shareholder value. The "sell to cover" transaction is a minor, non-discretionary dilution event.
• Employees: The continued vesting schedule for a key executive may signal stability in leadership.

Next Steps

• Remaining performance stock units from the February 2025 grant are eligible to vest on February 28, 2027.
• The final tranche of performance stock units from the February 2025 grant is eligible to vest on February 28, 2028.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation events, specifically the vesting of performance stock units and a subsequent 'sell to cover' transaction for tax purposes. These are pre-scheduled and non-discretionary events that do not reflect a change in the company's fundamentals or the executive's discretionary view of the stock. Therefore, it provides no new information that would warrant a change in investment recommendation, suggesting a 'hold' position is appropriate based solely on this filing.

Keywords

Artivion, AORT, Lance A. Berry, SEC Form 4, Insider Trading, Performance Stock Units, Stock Vesting, Executive Compensation, Sell to Cover, Common Stock